1. Identification of Keratinocyte Mitogens: Implications for Hyperproliferation in Psoriasis and Atopic Dermatitis
    Hanna Niehues et al, 2022, JID Innovations CrossRef
  2. Differential expression of pro-inflammatory and anti-inflammatory genes of layer chicken bursa after experimental infection with infectious bursal disease virus
    Zhi-Yong Xu et al, 2019, Poultry Science CrossRef
  3. Platelet-released growth factors inhibit proliferation of primary keratinocytes in vitro
    Andreas Bayer et al, 2018, Annals of Anatomy - Anatomischer Anzeiger CrossRef
  4. Interleukin-17A and Keratinocytes in Psoriasis
    Masutaka Furue et al, 2020, International Journal of Molecular Sciences CrossRef
  5. Chronic Nodular Prurigo: An Update on the Pathogenesis and Treatment
    Lai-San Wong et al, 2022, International Journal of Molecular Sciences CrossRef
  6. Expression and activity of IL-17 receptor subunits in human cutaneous cells as targets for anti-IL-17 therapeutic antibodies
    Johannes Wohlrab et al, 2022, Biomedicine & Pharmacotherapy CrossRef
  7. Regulation of Filaggrin, Loricrin, and Involucrin by IL-4, IL-13, IL-17A, IL-22, AHR, and NRF2: Pathogenic Implications in Atopic Dermatitis
    Masutaka Furue, 2020, International Journal of Molecular Sciences CrossRef
  8. MiR‐486 promotes proliferation and suppresses apoptosis in myeloid cells by targeting Cebpa in vitro
    Jingwei Jiang et al, 2018, Cancer Medicine CrossRef
  9. The CCL20 and CCR6 axis in psoriasis
    Kazuhisa Furue et al, 2020, Scandinavian Journal of Immunology CrossRef
  10. Ixekizumab for treatment of adults with moderate-to-severe plaque psoriasis and psoriatic arthritis
    Trang T. Vu et al, 2016, Expert Review of Clinical Pharmacology CrossRef
  11. Downregulation of Cathepsin B Reduces Proliferation and Inflammatory Response and Facilitates Differentiation in Human HaCaT Keratinocytes, Ameliorating IL-17A and SAA-Induced Psoriasis-Like Lesion
    Di Xu et al, 2021, Inflammation CrossRef
  12. Long-Term and Clinically Relevant Full-Thickness Human Skin Equivalent for Psoriasis
    Smriti Singh et al, 2020, ACS Applied Bio Materials CrossRef
  13. RNAI-MEDIATED SILENCING OF MATRIX METALLOPROTEINASE 1 IN EPIDERMAL KERATINOCYTES INFLUENCES THE BIOLOGICAL EFFECTS OF INTERLEUKIN 17A
    J. A. Mogulevtseva et al, 2018, Vavilov Journal of Genetics and Breeding CrossRef
  14. Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis
    Emma Guttman-Yassky et al, 2019, Journal of Allergy and Clinical Immunology CrossRef
  15. Role of interleukin-23/interleukin-17 axis in T-cell-mediated actions in hypertension
    Akinori Higaki et al, 2021, Cardiovascular Research CrossRef
  16. Effects of IL-17 on Epidermal Development
    Emi Sato et al, 2022, Keratinocyte Biology - Structure and Function in the Epidermis CrossRef
  17. Epidermal CD147 expression plays a key role in IL-22-induced psoriatic dermatitis
    Cong Peng et al, 2017, Scientific Reports CrossRef
  18. Inhibition of sphingosine 1-phosphate lyase activates human keratinocyte differentiation and attenuates psoriasis in mice
    Suwon Jeon et al, 2020, Journal of Lipid Research CrossRef
  19. Interleukin-17 alters the biology of many cell types involved in the genesis of psoriasis, systemic inflammation and associated comorbidities
    James G. Krueger et al, 2018, Experimental Dermatology CrossRef
  20. Psoriasis and the TNF/IL23/IL17 axis
    Kazuhisa Furue et al, 2019, Giornale Italiano di Dermatologia e Venereologia CrossRef
  21. IL-17E (IL-25) and IL-17A Differentially Affect the Functions of Human Keratinocytes
    Julia Borowczyk et al, 2020, Journal of Investigative Dermatology CrossRef
  22. Pathogenic implication of epidermal scratch injury in psoriasis and atopic dermatitis
    Kazuhisa Furue et al, 2020, The Journal of Dermatology CrossRef
  23. Importance of lymphocyte–stromal cell interactions in autoimmune and inflammatory rheumatic diseases
    Mélissa Noack et al, 2021, Nature Reviews Rheumatology CrossRef
  24. Secukinumab in treating psoriatic arthritis
    Hana Ciferská et al, 2017, Klinická farmakologie a farmacie CrossRef